Amelioration of female menopausal syndrome by intravenous administration of autologous menstrual blood-derived stem cells

The present results suggest that the administration of MenSCs improved menopausal symptoms and regulated hormonal balance without any serious adverse events. This is the first report on the promising therapeutic potential of cell-based therapy using autologous MenSCs for female menopausal syndrome.